Correspondence on “ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)” by Miller et al-Reference-Cited by-同舟云学术

Correspondence on “ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)” by Miller et al

Published:2021-11 Issue: Volume: Page:
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

McGurk Kathryn A.,Zheng Sean L.,Henry Albert,Josephs Katherine,Edwards Matthew,de Marvao Antonio,Whiffin Nicola,Roberts Angharad,Lumbers Thomas R.,O’Regan Declan P.,Ware James S.

Funder

Medical Research Council

British Heart Foundation

NIHR Imperial Biomedical Research Centre

Wellcome Trust

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference10 articles.

1. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG);Miller;Genet Med,2021

2. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG);Miller;Genet Med,2021